Cargando…

Intellectual property : valuation, exploitation, and infringement damages 2015 cumulative supplement, 11th ed. /

An updated, comprehensive guide to monetizing intellectual property assets. Intellectual Property, Valuation, Exploration, and Infringement Damages removes complexity and provides solutions to the challenge of placing a dollar amount on intellectual property. This revised and updated cumulative supp...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor principal: Parr, Russell L.
Otros Autores: Smith, Gordon V.
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Hoboken, N.J. : Wiley, 2015.
Temas:
Acceso en línea:Texto completo
Tabla de Contenidos:
  • Become a Subscriber!; Title Page; Copyright; About the Authors; About the Contributors; Preface; Part 1: Valuation; Chapter 1A: Intellectual Property Landscape (New); 1A.1 80% of Corporate Value Is Intellectual Property and Intangible Assets; 1A.2 Over Seven Million Patents; 1A.3 Corporations Own the Most Patents; 1A.4 All Industries Are Patenting Inventions; 1A.5 Trademarks; 1A.6 Trademarks Are Supported with Huge Ad Spending; 1A.7 Copyrights; 1A.8 Trade Secrets; 1A.9 Business of Licensing; Chapter 1B: U.S. Congress Flirts with Disaster (New); 1B.1 Patent Litigation Venue.
  • 1B.2 Patent Infringement Damages1B.3 Injunctions for Only Competitors; 1B.4 Harming Our Only Economic Advantage; Chapter 12A: Risk-Adjusted Cash Flows (New); 12A.1 Required Rates of Return; 12A.2 Capital Asset Pricing Model; 12A.3 Build-up Method; 12A.4 Venture Capital Rates of Return; 12A.5 Probability of Success; 12A.6 Conclusion; Chapter 12B: Dealing with Risk and Uncertainty in Intellectual Property Valuation and Exploitation (New); 12B.1 Risk versus Uncertainty; 12B.2 Decision Analysis and Decision Trees; 12B.3 Decision Tree Components and Conventions; 12B.4 Monte Carlo Techniques26.
  • 12B.5 Markov Chains12B.6 Obtaining Information from Indirect Observation: Shadow Pricing; 12B.7 Bayesian Analysis; 12B.8 Option Pricing Models; 12B.9 Limitations on Rationality in Decision Making: The Effects of Perception and Biases on Decision Making; 12B.10 Conclusion; Chapter 14A: Rights of Privacy, Publicity, and Celebrity Persona (New); 14A.1 Introduction; 14A.2 Legal Underpinnings; 14A.3 Trademark Rights; 14A.4 Copyright; 14A.5 Legal Uncertainties and Solutions; 14A.6 A Photography Issue; 14A.7 Conclusion; Chapter 14B: Intellectual Property and Intangible Asset Volatility (NEW).
  • Part 2: LicensingChapter 27A: Royalty Rates and License Fees for Technology (New); 27A.1 Royalty Rates; 27A.2 Per Unit Royalties; 27A.3 Royalties Based on Profitability; 27A.4 License Fees; 27A.5 Medical Device Industry Royalty Rates; 27A.6 Medical Device Industry License Fee Distribution; 27A.7 Conclusion; Chapter 27B: License Fees and Royalty Rate Frequency for Technology (New); 27B.1 Real Deal Royalty Rates; 27B.2 Per Unit Royalties; 27B.3 License Fees; 27B.4 Conclusion; Chapter 27C: Royalty Rates and License Fees for Pharmaceuticals and Biotechnology (New).
  • 27C.1 The Parties-Licensing between Corporations Dominates27C.2 Royalty Rates; 27C.3 License Fees; 27C.4 Key Technologies; 27C.5 Developmental Stages of Technology; 27C.6 Conclusion; Chapter 33A: The Magnitude and Meaning of Royalty Misreporting (New); 33A.1 Introduction; 33A.2 "Why?" versus "How?"; 33A.3 Math Errors: 5% Error Rate; 33A.4 Royalty Rate Errors: 4% Error Rate; 33A.5 Transfer Prices: 4% Error Rate; 33A.6 Unreported Benchmarks and Milestones:5% Error Rate; 33A.7 Unreported Sales: 16% Error Rate; 33A.8 Disallowed Deductions: 9% Error Rate.